Sequent Scien.

Part of MojoOne Strategy

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE807F01027
NSEID: SEQUENT
BSEID: 512529

INR

199.70

-7.73 (-3.73%)

BSENSE

Dec 05

BSE+NSE Vol: 22.97 lacs

Click here to access the older version

{
  "main_header": {
    "sid": 213056,
    "name": "Sequent Scien.",
    "stock_name": "Sequent Scien.",
    "full_name": "Sequent Scientific Ltd",
    "name_url": "stocks-analysis/sequent-scien",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "199.70",
    "chg": -7.73,
    "chgp": "-3.73%",
    "dir": -1,
    "prev_price": "207.43",
    "mcapval": "5,170.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 512529,
    "symbol": "SEQUENT",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE807F01027",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "22.97 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sequent-scien-213056-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sequent-scien-213056-1&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Sequent Scien. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sequent-scien-fallingrising-3747203",
        "imagepath": "",
        "date": "2025-12-05 00:48:51",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>On 04-Dec, Sequent Scientific’s shares closed at ₹207.65, down ₹5.05 or 2.37% from the previous session. This decline is part of a broader short-term downtrend, with the stock losing 8.28% over the past week, significantly underperforming the Sensex benchmark, which fell only 0.53% in the same period. Over the last month, the stock has declined 5.20%, whereas the Sensex gained 2.16%, highlighting a divergence from the broader market’s positive momentum.</p>\n<p>The stock has been on a consecutive five-day losing streak, accumulating an 8.64% drop during this period. Intraday, the share price touched a low of ₹206.20, reflecting a 3.06% decline on the day. This short-term weakness contrasts with the stock’s longer-term performance, w..."
      },
      {
        "title": "Sequent Scientific Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sequent-scientific-technical-momentum-shifts-amid-mixed-market-signals-3742737",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SequentScientif_technicaldot_3742737.png",
        "date": "2025-12-03 08:01:54",
        "description": "Sequent Scientific, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a strongly bullish stance to a more tempered mildly bullish outlook, underscoring the importance of closely monitoring technical indicators such as MACD, RSI, moving averages, and other momentum oscillators."
      },
      {
        "title": "Is Sequent Scien. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-sequent-scien-overvalued-or-undervalued-3739814",
        "imagepath": "",
        "date": "2025-12-02 08:08:12",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Understanding Sequent Scientific’s Valuation Metrics</strong></p>\n<p>Sequent Scientific currently trades at a price of ₹221.25, having seen a 52-week range between ₹111.00 and ₹260.30. The company’s price-to-earnings (PE) ratio stands at a striking 126.16, which is considerably higher than typical industry averages. This elevated PE ratio often signals high growth expectations priced into the stock. However, the price-to-book value of 6.92 and enterprise value to EBITDA (EV/EBITDA) ratio of 31.90 indicate that while the stock is priced richly, it is not excessively so when compared to its earnings before interest, taxes, depreciation, and amortisation.</p>\n<p>Return on capital employed (ROCE) at 10.17% and return on equity (ROE) at 5.48% reflect moderate profitability levels. These returns, ..."
      },
      {
        "title": "Sequent Scien. Sees Revision in Market Assessment Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sequent-scien-upgraded-from-sell-to-hold-by-marketsmojo-on-2-sep-2025-3735288",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SequentScien_mojoScore_3735288.png",
        "date": "2025-11-28 10:04:56",
        "description": "Sequent Scien., a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a revision in its market evaluation. This shift reflects a nuanced view of the company’s financial and technical parameters, highlighting both promising trends and ongoing challenges within its operational and valuation metrics."
      },
      {
        "title": "Sequent Scientific Hits Intraday Low Amid Price Pressure and Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sequent-scientific-hits-intraday-low-amid-price-pressure-on-24-nov-2025-3725847",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SequentScientif_priceRelatedfactors_3725847.png",
        "date": "2025-11-24 15:15:53",
        "description": "Sequent Scientific experienced notable intraday weakness on 24 Nov 2025, touching a low of Rs 221.1 as the stock faced significant price pressure. The decline occurred amid broader market volatility, with the Sensex reversing sharply after a positive start to the day."
      },
      {
        "title": "Sequent Scientific Hits Intraday Low Amid Price Pressure and Market Sentiment",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sequent-scientific-hits-intraday-low-amid-price-pressure-on-20-nov-2025-3718476",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SequentScientif_priceRelatedfactors_3718476.png",
        "date": "2025-11-20 15:46:24",
        "description": "Sequent Scientific experienced a notable intraday decline on 20 Nov 2025, touching a low of Rs 234, reflecting a price pressure of 7.12% during the trading session. This movement contrasts with the broader market trend, where the Sensex recorded gains and reached a new 52-week high."
      },
      {
        "title": "Sequent Scientific Hits New 52-Week High at Rs.260.3 Mark",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sequent-scientific-hits-new-52-week-high-at-rs2603-3714985",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SequentScientif_priceRelatedfactors_3714985.png",
        "date": "2025-11-19 09:43:59",
        "description": "Sequent Scientific, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.260.3 today, marking a significant milestone in its stock performance. This peak reflects the stock’s sustained momentum over the past year amid a broader market environment showing cautious optimism."
      },
      {
        "title": "Why is Sequent Scien. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sequent-scien-fallingrising-3712855",
        "imagepath": "",
        "date": "2025-11-18 21:51:52",
        "description": "As of 18-Nov, Sequent Scientific Ltd is experiencing a price increase, currently at Rs. 247.65, reflecting a rise of 16.3 points or 7.05%. The stock has recently hit a new 52-week high of Rs. 249.5 and has shown strong performance today, outperforming its sector by 7.67%. Over the past week, the stock has gained 8.29%, and it has delivered a remarkable 22.03% return over the last month. The company has reported a significant growth in net profit of 209.15% and has declared positive results for the last seven consecutive quarters, contributing to investor confidence. Additionally, the stock's moving averages indicate it is trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day averages, suggesting a strong upward trend.\n\nIn the broader market context, Sequent Scientific's short-term performance has significantly outpaced the benchmark, with a 1-week return of 8.29% compared to the Sensex's 0.96%..."
      },
      {
        "title": "Sequent Scientific Hits Intraday High with Strong 7.2% Surge",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sequent-scientific-hits-intraday-high-with-72-surge-on-18-nov-2025-3712124",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SequentScientif_priceRelatedfactors_3712124.png",
        "date": "2025-11-18 15:07:04",
        "description": "Sequent Scientific recorded a robust intraday performance today, surging to a new 52-week high of Rs.249.15, marking a 7.69% rise during the trading session. This notable uptick outpaced the Pharmaceuticals & Biotechnology sector and the broader market, reflecting significant trading momentum."
      }
    ],
    "total": 217,
    "sid": "213056",
    "stock_news_url": "https://www.marketsmojo.com/news/sequent-scientific-213056"
  },
  "announcements": [
    {
      "details": "Sequent Scientific Limited has informed the Exchange regarding 'Pursuant to the provision of Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed copies of advertisement published in Business Standard newspaper providing snapshot of Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2019'.",
      "source": "NSE",
      "caption": "Sequent Scientific Limited - Updates",
      "datetime": "18-Nov-2019"
    },
    {
      "details": "Sequent Scientific Limited has informed the Exchange regarding 'Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you, that the Company has published extract of Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended September 30, 2019 in Free Press Journal (English Edition) and Navashakti (Marathi Edition) newspapers on November 14, 2019.",
      "source": "NSE",
      "caption": "Sequent Scientific Limited - Updates",
      "datetime": "15-Nov-2019"
    },
    {
      "details": "Sequent Scientific Limited has informed the Exchange regarding Appointment of Mr Krunal Shah as Company Secretary & Compliance Officer of the company w.e.f. November 13, 2019.",
      "source": "NSE",
      "caption": "Sequent Scientific Limited - Appointment",
      "datetime": "14-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sequent Scientific Ltd has declared <strong>25%</strong> dividend, ex-date: 08 Sep 21",
          "dt": "2021-09-08",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sequent Scientific Ltd has announced <strong>2:10</strong> stock split, ex-date: 25 Feb 16",
          "dt": "2016-02-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Sequent Scien. falling/rising?

2025-12-05 00:48:51

Recent Price Movement and Market Performance

On 04-Dec, Sequent Scientific’s shares closed at ₹207.65, down ₹5.05 or 2.37% from the previous session. This decline is part of a broader short-term downtrend, with the stock losing 8.28% over the past week, significantly underperforming the Sensex benchmark, which fell only 0.53% in the same period. Over the last month, the stock has declined 5.20%, whereas the Sensex gained 2.16%, highlighting a divergence from the broader market’s positive momentum.

The stock has been on a consecutive five-day losing streak, accumulating an 8.64% drop during this period. Intraday, the share price touched a low of ₹206.20, reflecting a 3.06% decline on the day. This short-term weakness contrasts with the stock’s longer-term performance, w...

Sequent Scientific Technical Momentum Shifts Amid Mixed Market Signals

2025-12-03 08:01:54

Sequent Scientific, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a strongly bullish stance to a more tempered mildly bullish outlook, underscoring the importance of closely monitoring technical indicators such as MACD, RSI, moving averages, and other momentum oscillators.

Is Sequent Scien. overvalued or undervalued?

2025-12-02 08:08:12

Understanding Sequent Scientific’s Valuation Metrics

Sequent Scientific currently trades at a price of ₹221.25, having seen a 52-week range between ₹111.00 and ₹260.30. The company’s price-to-earnings (PE) ratio stands at a striking 126.16, which is considerably higher than typical industry averages. This elevated PE ratio often signals high growth expectations priced into the stock. However, the price-to-book value of 6.92 and enterprise value to EBITDA (EV/EBITDA) ratio of 31.90 indicate that while the stock is priced richly, it is not excessively so when compared to its earnings before interest, taxes, depreciation, and amortisation.

Return on capital employed (ROCE) at 10.17% and return on equity (ROE) at 5.48% reflect moderate profitability levels. These returns, ...

Sequent Scien. Sees Revision in Market Assessment Amid Mixed Financial Signals

2025-11-28 10:04:56

Sequent Scien., a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently experienced a revision in its market evaluation. This shift reflects a nuanced view of the company’s financial and technical parameters, highlighting both promising trends and ongoing challenges within its operational and valuation metrics.

Sequent Scientific Hits Intraday Low Amid Price Pressure and Market Volatility

2025-11-24 15:15:53

Sequent Scientific experienced notable intraday weakness on 24 Nov 2025, touching a low of Rs 221.1 as the stock faced significant price pressure. The decline occurred amid broader market volatility, with the Sensex reversing sharply after a positive start to the day.

Sequent Scientific Hits Intraday Low Amid Price Pressure and Market Sentiment

2025-11-20 15:46:24

Sequent Scientific experienced a notable intraday decline on 20 Nov 2025, touching a low of Rs 234, reflecting a price pressure of 7.12% during the trading session. This movement contrasts with the broader market trend, where the Sensex recorded gains and reached a new 52-week high.

Sequent Scientific Hits New 52-Week High at Rs.260.3 Mark

2025-11-19 09:43:59

Sequent Scientific, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.260.3 today, marking a significant milestone in its stock performance. This peak reflects the stock’s sustained momentum over the past year amid a broader market environment showing cautious optimism.

Why is Sequent Scien. falling/rising?

2025-11-18 21:51:52

As of 18-Nov, Sequent Scientific Ltd is experiencing a price increase, currently at Rs. 247.65, reflecting a rise of 16.3 points or 7.05%. The stock has recently hit a new 52-week high of Rs. 249.5 and has shown strong performance today, outperforming its sector by 7.67%. Over the past week, the stock has gained 8.29%, and it has delivered a remarkable 22.03% return over the last month. The company has reported a significant growth in net profit of 209.15% and has declared positive results for the last seven consecutive quarters, contributing to investor confidence. Additionally, the stock's moving averages indicate it is trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day averages, suggesting a strong upward trend. In the broader market context, Sequent Scientific's short-term performance has significantly outpaced the benchmark, with a 1-week return of 8.29% compared to the Sensex's 0.96%...

Sequent Scientific Hits Intraday High with Strong 7.2% Surge

2025-11-18 15:07:04

Sequent Scientific recorded a robust intraday performance today, surging to a new 52-week high of Rs.249.15, marking a 7.69% rise during the trading session. This notable uptick outpaced the Pharmaceuticals & Biotechnology sector and the broader market, reflecting significant trading momentum.

View All News

Announcement

Sequent Scientific Limited - Updates

18-Nov-2019 | Source : NSE

Sequent Scientific Limited has informed the Exchange regarding 'Pursuant to the provision of Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed copies of advertisement published in Business Standard newspaper providing snapshot of Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2019'.

Sequent Scientific Limited - Updates

15-Nov-2019 | Source : NSE

Sequent Scientific Limited has informed the Exchange regarding 'Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you, that the Company has published extract of Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended September 30, 2019 in Free Press Journal (English Edition) and Navashakti (Marathi Edition) newspapers on November 14, 2019.

Sequent Scientific Limited - Appointment

14-Nov-2019 | Source : NSE

Sequent Scientific Limited has informed the Exchange regarding Appointment of Mr Krunal Shah as Company Secretary & Compliance Officer of the company w.e.f. November 13, 2019.